<DOC>
	<DOCNO>NCT02796105</DOCNO>
	<brief_summary>Evaluation efficacy safety medroxiprogesterone acetate ( Progevera 10 mg® ) versus GnRh antagonist ( Orgalutran® ) ovarian stimulation cycle oocyte donor</brief_summary>
	<brief_title>Progevera 10 mg® Versus Orgalutran® Ovarian Stimulation Cycles Oocyte Donors</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Oocyte donor include oocyte donation program Clinica EUGIN . 1st oocyte donation cycle Clínica EUGIN . Polycistic Ovarian syndrome ( PCOs ) . Estradiol level day 2 menstrual cycle &gt; 70 pg/ml . Hormone treatment 3 month oocyte donation cycle . Medical contraindication treatment use study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>